CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI New Evidence Supporting a Novel Conceptual Framework for Distinguishing Proportionate and Disproportionate Functional Mitral Regurgitation Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club A prospective, randomized, open-label trial of 6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction: Rationale and design of the Revascularization of left main coronary artery Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective

Editorial2017 Dec 12;70(23):2875-2877.

JOURNAL:J Am Coll Cardiol. Article Link

Can the Vanishing Stent Reappear? Fix the Technique, or Fix the Device?

King SB 3rd, Gogas BD. Keywords: bioresorbable vascular scaffold; prognosis; randomized trial; stent; technique; thrombosis

FULL TEXT PDF